Surgical Science Sweden AB Cash Flow Quality Index
Surgical Science Sweden AB cash flow quality index. Surgical Science Sweden AB (SUS) has a Cash Flow Quality Index of 0.73x as of June 2026. Operating cash flow of Skr15.31 Million is below net income of Skr20.85 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of Surgical Science Sweden AB to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Surgical Science Sweden AB (2015–2025)
Cash flow quality index of Surgical Science Sweden AB from 2015 to 2025. Historical Cash Flow Quality Index for Surgical Science Sweden AB across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Surgical Science Sweden AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Surgical Science Sweden AB Cash Flow Quality Index by Year (2015–2025)
Surgical Science Sweden AB cash flow quality index by year from 2015 to 2025. Year-by-year earnings quality comparison for Surgical Science Sweden AB. For the full cash flow conversion analysis, see SUS cash generation efficiency.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.19x | Skr79.80 Million | Skr66.82 Million | ▲ +14.6% |
| 2024 | 1.04x | Skr137.22 Million | Skr131.65 Million | ▲ +2.3% |
| 2023 | 1.02x | Skr238.29 Million | Skr233.97 Million | ▲ +27.8% |
| 2022 | 0.80x | Skr129.49 Million | Skr162.54 Million | ▲ +15.2% |
| 2021 | 0.69x | Skr39.08 Million | Skr56.52 Million | ▼ -40.5% |
| 2020 | 1.16x | Skr23.23 Million | Skr19.97 Million | ▼ -68.0% |
| 2019 | 3.64x | Skr55.20 Million | Skr15.18 Million | ▼ -12.7% |
| 2015 | 4.17x | Skr7.50 Million | Skr1.80 Million | — |